MediXall Group Inkomsten in het verleden
Verleden criteriumcontroles 0/6
MediXall Group has been growing earnings at an average annual rate of 27.1%, while the Healthcare Services industry saw earnings growing at 14% annually.
Belangrijke informatie
27.1%
Groei van de winst
33.2%
Groei van de winst per aandeel
| Healthcare Services Groei van de industrie | 1.7% |
| Inkomstengroei | n/a |
| Rendement op eigen vermogen | n/a |
| Nettomarge | -2,213.2% |
| Laatste winstupdate | 30 Sep 2023 |
Recente prestatie-updates uit het verleden
Geen updates
Recent updates
Opbrengsten en kosten
Hoe MediXall Group geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 23 | 0 | -5 | 3 | 0 |
| 30 Jun 23 | 0 | -5 | 3 | 0 |
| 31 Mar 23 | 0 | -6 | 3 | 0 |
| 31 Dec 22 | 0 | -7 | 3 | 0 |
| 30 Sep 22 | 0 | -7 | 3 | 0 |
| 30 Jun 22 | 0 | -7 | 3 | 0 |
| 31 Mar 22 | 0 | -8 | 3 | 0 |
| 31 Dec 21 | 0 | -6 | 3 | 0 |
| 30 Sep 21 | 0 | -7 | 4 | 0 |
| 30 Jun 21 | 0 | -6 | 3 | 0 |
| 31 Mar 21 | 0 | -6 | 3 | 0 |
| 31 Dec 20 | 0 | -6 | 3 | 0 |
| 30 Sep 20 | 0 | -5 | 3 | 0 |
| 30 Jun 20 | 0 | -5 | 3 | 0 |
| 31 Mar 20 | 0 | -5 | 2 | 0 |
| 31 Dec 19 | 0 | -3 | 2 | 0 |
| 30 Sep 19 | 0 | -3 | 2 | 0 |
| 30 Jun 19 | 0 | -3 | 2 | 0 |
| 31 Mar 19 | 0 | -3 | 1 | 0 |
| 31 Dec 18 | 0 | -3 | 1 | 0 |
| 30 Sep 18 | 0 | -3 | 1 | 0 |
| 30 Jun 18 | 0 | -2 | 1 | 0 |
| 31 Mar 18 | 0 | -2 | 1 | 0 |
| 31 Dec 17 | 0 | -2 | 1 | 0 |
| 30 Sep 17 | 0 | -1 | 1 | 0 |
| 30 Jun 17 | 0 | -1 | 1 | 0 |
| 31 Mar 17 | 0 | -1 | 1 | 0 |
| 31 Dec 16 | 0 | -1 | 0 | 0 |
Kwaliteitswinsten: MDXL is currently unprofitable.
Groeiende winstmarge: MDXL is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: Insufficient data to determine if MDXL's year-on-year earnings growth rate was positive over the past 5 years.
Versnelling van de groei: Unable to compare MDXL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: MDXL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (35.1%).
Rendement op eigen vermogen
Hoge ROE: MDXL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.